Clinical trial / 1988
A gastric bubble adjunctive to diet and behavioral therapy did not significantly improve weight loss compared to sham treatment and caused notable side effects.
Ninety patients were randomized into three groups (bubble-sham, sham-bubble, and bubble-bubble) across two successive 12-week periods, alongside diet and behavioral modification therapy. All groups lost weight, but there were no significant differences among groups at 12 or 24 weeks for weight loss or BMI changes. Cumulative mean weight loss at 24 weeks was 23 lb (bubble-sham), 16 lb (sham-bubble), and 18 lb (bubble-bubble). Side effects included gastric erosions (26%), gastric ulcers (14%), small bowel obstruction (2%), Mallory-Weiss tears (11%), and esophageal laceration (1%).
- Study type
- Double-blind randomized crossover trial
- Who was studied
- 90 patients with exogenous obesity (61 completed the 24-week study)
- What was measured
- Weight loss and change in body mass index (BMI) at 12 and 24 weeks; side effects
THE PAPER
Double-blind controlled trial of the Garren-Edwards gastric bubble: an adjunctive treatment for exogenous obesity.
Benjamin SB, Maher KA, Cattau EL, Collen MJ, Fleischer DE, Lewis JH, Ciarleglio CA, Earll JM, Schaffer S, Mirkin K. Gastroenterology, 1988.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.